Allworth Financial LP Esperion Therapeutics, Inc. Transaction History
Allworth Financial LP
- $22 Billion
- Q3 2025
A detailed history of Allworth Financial LP transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,000 shares of ESPR stock, worth $2,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$2,900
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ESPR
# of Institutions
220Shares Held
116MCall Options Held
643KPut Options Held
769K-
Vanguard Group Inc Valley Forge, PA14.9MShares$43.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY14MShares$40.6 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.75MShares$28.3 Million0.51% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT7.06MShares$20.5 Million0.1% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.4 Million7.68% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $193M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...